Abstract. The n-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), found in fish oil, exert a number of beneficial effects, and they are used in the treatment of hyperlipidemia. In recent years, EPA and DHA have been found to affect cancer cell proliferation. In the present study, PC3 cells, which are androgen-independent prostate cancer cells that resemble castration-resistant prostate cancer cells, were used to investigate a possible novel treatment for castration-resistant prostate cancer. The PC3 cells were cultured and incubated with various concentrations of EPA or DHA. Cancer proliferation was confirmed by trypan blue microscopy. Invasion and migration assays were used in the upper chamber in PC3 cells, and serum-free medium and various concentrations of EPA or DHA were placed in the lower chamber in serum-containing medium. EPA and DHA decreased PC3 cell proliferation, invasion and migration. The effect of EPA on PC3 cells was dose-dependent and significant differences were observed at concentrations of 100 and 200 µg/ml. The effect of DHA on PC3 cells was similar to that of EPA. In the migration assay, EPA exerted almost no effects at 25 µg/ml, but migration was reduced at 50 µg/ml. Similar to EPA, DHA exerted almost no effects at 25 µg/ml, but further reduction was observed at the 50 µg/ml concentration. In the invasion assay, EPA at 25 µg/ml was not significantly different from the control, but suppressed invasion at 50 µg/ml. DHA decreased invasion compared with the control at 25 µg/ml, whereas invasion was significantly reduced at a DHA concentration of 50 µg/ml. In conclusion, it was demonstrated that EPA and DHA were effective in decreasing the proliferation, invasion and migration of prostate PC3 cancer cells. However, the detailed underlying mechanisms have not yet been fully elucidated.
Introduction
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are n-3 fatty acids that have several beneficial effects, including decreasing the plasma triglyceride concentration, lipoprotein metabolism (1,2), inhibiting platelet aggregation by collagen (3) , and improving the reduced elasticity of the arterial walls through the endothelium-dependent relaxation response in rabbits (4) . For these reasons, DHA and EPA are clinically used in Japan. In recent years, n-3 fatty acids have been shown to decrease the proliferation of cancer cells in colon, breast and liver cancer, as well as neuroblastoma. In addition, n-3 fatty acids may be used in cancer cachexia; the combination of chemotherapy and n-3 fatty acids was helpful in the curative as well as the palliative clinical setting (5) , but a systematic review did not evaluate the balance of their cost-effectiveness against their utility (6) . A number of studies have investigated cancer cell growth; however, only a limited number of studies have examined invasion and metastasis in prostate cancer, which exhibits an increasing prevalence. In the present study, the PC3 prostate cancer cell line was used, which is an androgen-independent human prostate cancer cell line that is similar to castration-resistant prostate cancer. A common metastatic organ in prostate cancer is bone, and the PC3 cell line was derived from a bone-metastatic prostate cancer patient. Therefore, the aim of the present study was to determine whether EPA and DHA inhibit the proliferation, invasion and migration of PC3 cells, in order to explore a possible novel method for the treatment of castration-resistant prostate cancer.
Materials and methods
Proliferation. PC3 cells were grown in RPMI-1640 culture medium (Wako, Tokyo, Japan) supplemented with 5% 2x10 5 ) were suspended in the upper chamber of the Transwell inserts. The medium of the upper chamber was serum-free RPMI-1640 containing different concentrations of EPA or DHA. RPMI-1640 containing 10% FBS was used as chemoattractant in the lower chamber. At 24 or 48 h after incubation, the cells were washed with PBS twice and cells on the upper chambers were removed with a cotton swab soaked in PBS. Migrating or invading cells were fixed with 100% methanol and stained with 0.1% crystal violet solution. Migrating or invading cells in four randomly selected fields on the underside of the inserts were counted under a light microscope.
Reagent and cell culture. EPA and DHA (Sigma-Aldrich, St. Louis, MO, USA) were dissolved in 99% isopropanol. The desired concentration was reached by dilution in serum-free medium with 3% BSA. This solution was used for all studies. PC3 cells were cultured in RPMI-1640 medium in a 10-cm dish. When the cells were 70-80% confluent, they were passaged. After this step, the medium was changed at 24 and 48 h.
Results
Effects of DHA and EPA on PC3 cell proliferation. EPA and DHA decreased PC3 cell proliferation. The effect of EPA on PC3 cells was dose-dependent and significant differences were observed at concentrations of 100 and 200 µg/ml. The effect of DHA on PC3 cells was also significant at 100 and 200 µg/ml (Fig. 1) . As seen in the photomicrographs of untreated and treated PC-3 cells, the number of surviving cells decreased gradually in response to the increasing concentrations of EPA and DHA (Fig. 2) .
Effects of EPA and DHA on PC3 cell migration and invasion.
EPA and DHA inhibited the invasion (Fig. 3 ) and migration (Fig. 4) of PC3 cells. In the invasion assay, EPA did not significantly inhibit invasion at a concentration of 25 µg/ml compared with the control, but significantly suppressed invasion at 50 µg/ml. Invasion was significantly reduced at a DHA concentration of 25 and 50 µg/ml. In the migration assay, DHA and EPA exerted almost identical effects at 25 µg/ml, but further reduction of cell migration was observed at a concentration of 50 µg/ml.
Discussion
The results of the present study demonstrated that EPA and DHA exert a potent effect on cancer cells. EPA and DHA decreased the proliferation, invasion and migration in the PC3 prostate cancer cell line. Previous studies on this subject have used DU145, an androgen-independent prostate cancer cell line, obtained from brain metastasis of prostate cancer. It has been demonstrated the inhibitory effects of n-3 fatty acids on prostate cancer cells in culture suggest interference with growth factor signaling (7). It was also reported that LNCaP cell growth was inhibited by EPA and DHA (8) . The effect of EPA and DHA on the proliferation and invasion of the breast cancer cell lines MDA-MB-231 and MDA-231 Luc and the effect of EPA and DHA on breast cancer metastasis to bone following intracardiac injection of MDA-MB-231 and MDA-231-Luc cells was also evaluated in other studies (9, 10) . In brief, MDA-MB-231 cells were injected into mice that were fed experimental diets containing EPA or DHA. It was concluded that DHA inhibited the proliferation of cancer cells in bone metastasis compared with EPA (9) . It was also demonstrated that there is an association between PC3 cell invasion and voltage-gated sodium channels; the data suggested that EPA inhibited the sodium current and downregulated sodium channel function (10).
As mentioned above, a study involving the DU145 prostate cancer cell line demonstrated that EPA decreased cell proliferation, the effect of DHA on proliferation did not differ significantly from the control (7). However, another study reported that EPA and DHA induced dose-dependent decreases in PC3 cell proliferation and the effects were similar between EPA and DHA (11) .
In HT29 and HT29-dx colon cancer cells, omega-3 fatty acids inhibited cholesterol synthesis through ubitiquination of HMG-CoA reductase. The inhibition of HT29 cell proliferation and cholesterol synthesis was correlated with cell viability (12) .
The addition of EPA, DHA and α-linoleic acid has been shown to decrease proliferation in neuroblastoma IMR-32 cells in a study investigating the effect of eicosanoids, such as lipoxin A4, prostaglandin and leukotriene, on IMR-32 cells (13) .
A study involving HepG2 cells and normal human liver L-02 cells demonstrated that HepG2 cell proliferation decreased dose-dependently with EPA treatment. The effect was not different between incubation times of 24 and 48 h, but L-02 cell proliferation was not affected by EPA. In addition, the study reported that EPA induced the degradation of pro-caspase-9 and pro-caspase-3 in HepG2 cells, through induction of MPTP and release of cytochrome C from the mitochondria to the cytoplasm in a time-dependent manner (14) .
Those studies demonstrated that EPA and DHA decreased cancer cell proliferation. EPA and DHA exerted a number of effects, including changes in intracellular ion concentration, ubiquitination, and the inhibition of multidrug resistance proteins. Our results demonstrated that EPA decreased cancer proliferation more efficiently compared with DHA, suggesting a possible treatment for metastatic castration-resistant prostate cancer. In addition, PC3 cells expressed phosphoinositide 3 kinase (PI3K)/AKT-related PIP5K1α (15) , and HBx transfection in HepG2 cells led to the expression of nuclear factor (NF)-κβ (16) . NF-κβ is downstream of PI3K/AKT and is a transcription factor that acts on a variety of genes. However, those studies did not demonstrate the effects of EPA and DHA, although EPA and DHA were shown to inhibit NF-κβ (17, 18) . Therefore, similar effects may also be expected in PC3 cells, although the underlying mechanisms in PC3 cells require further elucidation.
In conclusion, EPA and DHA inhibited invasion and migration as well as proliferation of PC-3 cells. Furthermore, it has been demonstrated that EPA and DHA exerted independent effects on decreasing the proliferation and invasion of prostate PC3 cancer cells. However, the detailed underlying mechanisms have not yet been fully elucidated.
